These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6474171)

  • 1. Bimolane: structure determination indicates anticancer activity is attributable to ICRF-154.
    Camerman N; Hempel A; Camerman A
    Science; 1984 Sep; 225(4667):1165-6. PubMed ID: 6474171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II.
    Vuong MC; Hasegawa LS; Eastmond DA
    Mutat Res; 2013 Jan; 750(1-2):63-71. PubMed ID: 23000430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evaluation of bimolane and analogs as potential antitumor agents.
    Ren YF; Otter GM; Schmid FA
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):493-7. PubMed ID: 3859415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic activities and mechanisms of bisdioxopiperazine compounds.
    Lu DY; Lu TR
    Anticancer Agents Med Chem; 2010 Sep; 10(7):564-70. PubMed ID: 20950258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of bimolane on cell cycle cytokinesis in human lymphocytes in vitro].
    Xue KX; Ma GJ; Wu JZ
    Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):87-9. PubMed ID: 8010096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reproductive toxicity of bimolane in mice and rabbits].
    Chen LJ; Wang MY; Liu MZ
    Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):557-60. PubMed ID: 2641857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the protective effect of ICRF-187 and structurally related analogues against acute daunorubicin toxicity in Syrian golden hamsters.
    Herman EH; el-Hage AN; Creighton AM; Witiak DT; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):39-55. PubMed ID: 3922023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutagenic effects of bimolane].
    Chen SQ; Xue KX; Wu JZ; Ma GJ
    Zhongguo Yao Li Xue Bao; 1995 Nov; 16(6):531-3. PubMed ID: 8732050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimolane: in vitro inhibitor of human topoisomerase II.
    Frantz CE; Smith H; Eades DM; Grosovsky AJ; Eastmond DA
    Cancer Lett; 1997 Dec; 120(2):135-40. PubMed ID: 9461029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cytokinetic effects of bimolane (AT-1727) on S180 cells].
    Lin C; Zhang TM
    Yao Xue Xue Bao; 1982 Sep; 17(9):654-7. PubMed ID: 7158349
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological studies on bimolane (AT-1727), a new antineoplastic agent (author's transl)].
    Zhang TM; Chen ZY; Lin C
    Yao Xue Xue Bao; 1980 Oct; 15(10):577-83. PubMed ID: 7257778
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.
    Lu DY; Huang M; Xu CH; Yang WY; Hu CX; Lin LP; Tong LJ; Li MH; Lu W; Zhang XW; Ding J
    BMC Pharmacol; 2005 Jun; 5():11. PubMed ID: 15963241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of bimolane on immune responses in mice].
    Dan N; Zhang TM
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):471-4. PubMed ID: 3064552
    [No Abstract]   [Full Text] [Related]  

  • 14. Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
    Roy SK; Eastmond DA
    Mutat Res; 2011 Dec; 726(2):181-7. PubMed ID: 21944901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between radiation sensitization and DNA damage by bimolane].
    Zhang YP; Chen YN; Fan GC; Xia SX
    Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):177-80. PubMed ID: 2959009
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of ICRF-154 in combination with other anticancer agents in vitro.
    Kano Y; Narita T; Suzuki K; Akutsu M; Suda K; Sakamoto S; Miura Y
    Br J Cancer; 1992 Aug; 66(2):281-6. PubMed ID: 1503899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activities and mechanisms of bisdioxopiperazine compounds probimane and MST-16.
    Lu DY; Lu TR
    Anticancer Agents Med Chem; 2010 Jan; 10(1):78-91. PubMed ID: 19845502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of bimolane and probimane on the incorporation of (3H)TdR, (3H)UR and (3H)Leu into Ehrlich ascites carcinoma cells iv vitro].
    Wang MY; Liu TX; Li GD; Zhang TM
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):367-9. PubMed ID: 3195348
    [No Abstract]   [Full Text] [Related]  

  • 19. Metal binding by pharmaceuticals. Part 2. Interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192.
    Huang ZX; May PM; Quinlan KM; Williams DR; Creighton AM
    Agents Actions; 1982 Oct; 12(4):536-42. PubMed ID: 7180739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UHPLC-MS/MS method for analysis of sobuzoxane, its active form ICRF-154 and metabolite EDTA-diamide and its application to bioactivation study.
    Reimerová P; Jirkovská A; Piskáčková HB; Karabanovich G; Roh J; Šimůnek T; Štěrbová-Kovaříková P
    Sci Rep; 2019 Mar; 9(1):4524. PubMed ID: 30872754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.